Clinical Trial Update: Drug Screening Using Novel IMD in Renal Cell Carcinoma [Phase 1]

View source ↗

Summary

This update notes an ongoing Phase 1 trial evaluating a novel investigational drug (Novel IMD) for renal cell carcinoma, with enrollment by invitation. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Novel IMD

Snippet

Sponsor: Oliver Jonas | Conditions: Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma | Phase 1 | Status: ENROLLING_BY_INVITATION